Effect of defibrillation on the performance of an implantable vagus nerve stimulation system

[1]  J. Božić,et al.  Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers , 2020, World journal of cardiology.

[2]  J. Butler,et al.  Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design. , 2019, Circulation. Heart failure.

[3]  B. KenKnight,et al.  LONG-TERM FOLLOW-UP OF REDUCED EJECTION FRACTION HEART FAILURE PATIENTS RECEIVING AUTONOMIC REGULATION THERAPY IN THE ANTHEM-HF PILOT STUDY , 2019, Journal of the American College of Cardiology.

[4]  B. KenKnight,et al.  Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF Study. , 2016, Journal of cardiac failure.

[5]  Imad Libbus,et al.  Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. , 2014, Journal of cardiac failure.

[6]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[7]  J. Ornato,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel , 2006, European heart journal.

[8]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..